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48
49
50This work was carried out to explore the unknown area of converting non-woven fibres, prepared by high
speed electrospinning, into a directly compressible blend by mixing with excipients. An experimental
design, with independent variables of compression force and fillers fraction, was realized to investigate
tabletability of electrospun material (EM) and to produce hard tablets with appropriate disintegration
time. The models proved to be adequate; fitted to the results and predicted values well for the optimal
tablet, which was found to be at 76.25% fillers fraction and 6 kN compression force. Besides standard
characterizations, distribution of EM was investigated by Raman mapping and scanning electron micro-
scopy revealing the propensity of EM to cover the surface of microcrystalline cellulose and not of man-
nitol. These analytical tools were also found to be useful at investigating the possible formation of the so-
called gelling polymer network in tablets. Scanning electron microscopic pictures of tablets confirmed
the maintenance of fibrous structure after compression. The moisture absorption of EM under increasing
humidity was studied by dynamic vapour sorption measurement, which suggested good physical stabil-
ity at 25 C and 60% relative humidity (corroborated by modulated DSC). These results demonstrate the
feasibility of a pharmaceutically acceptable downstream processing for EMs.
 2017 Published by Elsevier B.V. on behalf of The Society of Powder Technology Japan. All rights
reserved.5165
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771. Introduction
The challenge to make drug candidates of poor water solubility
suitable for commercialisation has been investigated for decades.
Several new ideas and technologies have been introduced in order
to enhance the bioavailability of such active pharmaceutical ingre-
dients (APIs). One of the most promising methods is the formation
of amorphous solid dispersions (ASDs) [1–3] owing to the advanta-
geous dissolution characteristics of the amorphous form of a drug.
To prepare these dispersions melt extrusion and spray drying have
emerged as the most important technologies and they are still
vividly investigated [4–8]. There are already several products on
the market containing ASD prepared by melt extrusion or spray78
79
80
81drying [2]. This also means that their downstream processing tech-
niques are developed [9] although in most cases many unique
issues can emerge during downstream of the solid dispersion,
which therefore needs to be investigated separately. For instance,
it might be challenging to mill a melt extrudate [10] or sometimes
the inherent poor compressibility of glassy or rubbery extrudates
requires a lot of fillers during compression [11,12]. In case of spray
dried dispersion the very low bulk density and the poor flowability
(due to the small particle size) often pose challenge to experts of
formulation [4,13]. A strategy has been developed recently to con-
trol and lower residual solvent content in spray-dried solid disper-
sion [14], which is of great importance of solvent technologies.
Tablets have obvious advantages over other formulations
whereby they add up to 80% of all formulations. Thus, formulation
of tablets is generally the first goal of a pharmaceutical company
with a new API (considering the patient compliance, convenient
storage, good mechanical properties and precise dosing) even if itrphous
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9 April 2017might be very challenging (e.g. creation of free flowing powder,
good compressibility). In case of ASD there is one extra, serious
challenge: the maintenance of the physical stability of the amor-
phous API during the whole downstream processing and storage
[9,15]. Granulation (especially wet granulation due to presence of
water) can induce phase separation and recrystallization [16,17]
of the API; therefore, direct compression is always the preferred
route. However, phase separation upon compression has been also
published [18,19]. Although the direct compression of ASDs might
be very complex it was chosen in the present work for forming
tablets from fibrous ASD.
Electrostatic spinning is a promising technology in the pharma-
ceutical industry for the production of ASDs for oral drug delivery
[20–28] or other applications [29–31]. Just like the aforementioned
two techniques (spray drying and melt extrusion), this is also a
continuous technology [32,33]. Electrospinning, for pharmaceuti-
cal purposes, has been investigating since 2003 (wound healing
and drug loaded nanofibres) [34,35]. Promising results in pharma
industry compatible scaling-up of electrospinning have been
achieved by creating high speed electrospinning [22,26]. However,
the downstream process has still never been investigated thor-
oughly. According to the author’s best knowledge, this is the first
paper discussing a trial to convert an electrospun nanofibrous
mat into a directly compressible powder to prepare tablets. The
investigation of dynamic vapour sorption of EM (and the related
modulated differential scanning calorimetry studies) was included
as well as an experimental design to optimize disintegration time
and tensile strength of tablets. Design of experiments approach is
often applied to optimize pharmaceutical powders [36]. Further-
more, unique peculiarities of EM have been determined in blends
and tablets with scanning electron microscopy and Raman
mapping.168
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1972. Materials and methods
2.1. Materials
Itraconazole (ITR), vinylpyrrolidone-vinyl acetate 6:4 copoly-
mer (PVPVA64) and magnesium stearate were provided by Janssen
Pharmaceutica (Beerse, Belgium). Aerosil 200 was purchased
from Evonik Industries (Essen, Germany). Microcrystalline cellu-
lose (Vivapur 200, MCC) was given by JRS Pharma (Rosenberg,
Germany). Lactose (Tablettose 80) was received from Meggle
Pharma (Wasserburg, Germany). Mannitol (Pearlitol 400DC) was
a kind gift from Roquette Pharma (Lestrem, France). Kollidon CL
was supplied by BASF (Ludwigshafen, Germany).
2.2. Preparation of electrospun material (EM) by high speed
electrospinning
The EM was prepared according to the description provided by
Nagy et al. [26]. The high speed electrospinning of the solution of
PVPVA64 (60%) and ITR (40%) in dichloromethane-ethanol (ratio
is 2:1; 225 mg PVPVA64 and 150 mg ITR in 1 ml solvent mixture)
was performed under the following conditions: 50 kV voltage,
40,000 rpm spinneret rotational speed, 1500 mL/h feeding rate,
ambient temperature. Further information and the basic character-
ization can be found in the aforementioned article. Prior to further
application the obtained sheet was passed through a sieve with
0.95 mm holes to make it suitable for blending.
2.3. Dynamic vapour sorption (DVS)
The DVS measurement was performed on a DVS Intrinsic instru-
ment (Surface Measurement Systems, London, UK). The relativePlease cite this article in press as: B. Démuth et al., Development and tableting
solid dispersion, Advanced Powder Technology (2017), http://dx.doi.org/10.10humidity (RH) was altered every hour by 10% from 0 up to 95%.
The measurement was carried out on two different temperatures:
25 C and 40 C. Two sorption and desorption cycles were col-
lected. The weight of the sample was measured continuously on
a SMS UltraBalanceTM.
2.4. Modulated differential scanning calorimetry (mDSC)
The EM was analysed in a DSC Q2000 instrument (TA Instru-
ments, Crawley, UK) by ‘‘Heat only” modulation mode, with a heat-
ing rate of 2 C/min, an amplitude of 0.318 C and a period of 60 s.
Standard aluminium pans (TA instruments) were applied with
crimping. Samples were kept in climate chambers at 25 C/60%
RH or 40 C/75% RH in open holders for the stability test.
2.5. Experimental design for preparation of fast disintegrating tablets
Firstly, a 22 design was planned in order to study the compres-
sion behaviour of the EM. The compression force and the fillers
fraction were selected as independent variables. The fraction of
the fillers was calculated from the weight of the fillers and EM to
highlight their ratio since it might have a significant effect on the
formation of a gelling polymer network [9]. Levels of independent
variables were selected based on preliminary experiments to
achieve an appropriate range for dependent variables (disintegra-
tion time and tensile strength). Centrum point measurements were
added to the design to check the adequacy. However, the fitted lin-
ear model was not adequate; hence the design was expanded to a
32 randomized full factorial design where quadratic effects can be
introduced. Composition of tableting blends can be observed in
Table 1, while levels of independent variables in Table 2. Tensile
strength and disintegration time were chosen as dependent vari-
ables since these values can be measured rather precisely and
independent variables might have a significant effect on them.
Tensile strength was calculated from hardness as the following
[37]:
T ¼ 2  H
p  t  d
where T is the tensile strength, H is hardness, t is thickness of the
tablets, while d is the diameter of the punches and tablets (9.5 mm).
Three tablets were measured in each case (to obtain standard
deviation and increase the reliability of the design) and individual
results were evaluated with Statistica 12 (Tulsa, Oklahoma, USA).
Every measurement was performed by one person to minimalize
the error. Our purpose was to optimize the compression force
and the composition for both dependent variables (low disintegra-
tion time, high tensile strength). Furthermore, it was intended to
maintain the structure of the fibres in tablets as good dissolution
properties can be attributed to this.
2.6. Preparation of blends
All excipients were pushed through a sieve with 0.95 mm holes
prior to blending. Mixing was carried out with a Turbula T2F
shaker-mixer (Glenn Mills Inc., Clifton, NJ, USA) for 5 min (magne-
sium stearate was mixed separately after other excipients).
2.7. Characterization of blends
A granulometry study was carried out for two blends (presum-
ably centre blend has intermediate characteristics). Bulk and
tapped densities were determined with 100 g of the blends.
Tapped density was measured after 1250 taps on an ERWEKA
SVM 12 tapping volumeter (Heusenstamm, Germany). Also 100 g
was applied for the sieve analysis. The used sieves: 1000 µm,of directly compressible powder from electrospun nanofibrous amorphous
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Table 1
The characterization of the terminal blends.
Material Blend 1 Centre blend Blend 2
Composition EM (mg) 125 (25%) 125 (22.4%) 125 (19.5%)
MCC (mg) 157 (31.5%) 183 (32.8%) 219 (34.2%)
Mannitol (mg) 157 (31.5%) 183 (32.8%) 219 (34.2%)
Kollidon CL (mg) 50 (10%) 56 (10%) 65 (10%)
Aerosil 200 (mg) 5 (1%) 5.6 (1%) 6.5 (1%)
Mg-stearate (mg) 5 (1%) 5.6 (1%) 6.5 (1%)
Flowability index
Flowability Bulk density 0.405 g/cm3 – 0.437 g/cm3
Tapped density 0.535 g/cm3 – 0.592 g/cm3
Hausner ratio 1.32 – 1.35
Carr index 24.3 – 26.2
Angle of reposea 58.13 – 55.20
True density 1.4079 g/cm3 – 1.4003 g/cm3
Sieve size Blend 1 Blend 2 EM
Particle size distribution Pan 31.8% 27.5% 22.6%
38 µm – – 28.0%
75 µm 12.9% 12.5% 8.10%
150 µm 14.8% 15.0% 39.4%
250 µm 36.8% 39.8% 1.45%
500 µm 3.30% 4.97% 0.40%
850 µm 0.25% 0.13% 0.05%
1000 µm 0.15% 0.10% –
a The used method is described in Section 2.7.
Table 2
The factors of the performed experimental design and the obtained results.
Batch number Compression force (kN) Fillers fraction (%)* Tensile strength (N/mm2) Disintegration time (s) Friability (%)
F1 3.0 71.4 0.67 ± 0.08 98 ± 9 1.09
F2 4.5 71.4 1.37 ± 0.10 289 ± 80 –
F3 6.0 71.4 2.23 ± 0.03 832 ± 56 0.08
F4 3.0 74.6 0.60 ± 0.01 38 ± 4 –
F5 4.5 74.6 1.20 ± 0.05 226 ± 24 0.34
F6 6.0 74.6 1.96 ± 0.12 343 ± 105 –
F7 3.0 77.8 0.52 ± 0.02 25 ± 4 1.01
F8 4.5 77.8 1.03 ± 0.03 93 ± 12 –
F9 6.0 77.8 1.84 ± 0.09 363 ± 15 0.02
Optimized tablets (OT) 6.0 76.25 1.94 ± 0.04 337 ± 36 –
mfillers
mfillersþmEM
 
 100.
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9 April 2017850 µm, 500 µm, 250 µm, 150 µm, 75 µm (in case of the pure EM a
38 µm sieve instead of the 1000 µm sieve in order to assess the dis-
tribution better at low particle sizes). Shaking was executed on a
Retsch sieve shaker (Haan, Germany) with applying 1.5 mm
amplitude for 5 min. Angle of repose was measured on an in-
house built flow meter containing a platform (with fixed diameter)
and a cylinder (with the same outer diameter like the platform).
Powder is poured into the cylinder where it touches the platform
and it starts to flow off of the flat platform due to the upward
movement of the cylinder (speed was fixed) while forming a pile.
Angle of repose can be determined based on the position of the
cylinder which has to be moved to the top of the pile after the fall-
ing of the powder stopped. This method generally provides larger
angle values but with lower deviations compared to the widely
used angle of repose determination. True densities of the blends
were determined on an Accupyc 1330 helium pycnometer
(Micromeritics, Atlanta, GA, USA).234
235
236
237
238
2392.8. Scanning electron microscope (SEM)
SEM images of the blends were taken with a Phenom Pro instru-
ment (PhenomWorld, Eindhoven, The Netherlands). Each specimen
was fixed by conductive double-sided carbon adhesive tape and
coated by gold prior SEM imaging. 10 kV was applied as accelerat-Please cite this article in press as: B. Démuth et al., Development and tableting
solid dispersion, Advanced Powder Technology (2017), http://dx.doi.org/10.101ing voltage and scanning was conducted with secondary electron
detection.
Broken surfaces of tablets were investigated by a JEOL 6380LVa
(JEOL, Tokyo, Japan) type scanning electron microscope. Tablets
were fixed by a conductive double-sided carbon adhesive tape
and coated by gold prior SEM imaging. The applied accelerating
voltage was 15 kV.2.9. Preparation of tablets
Tablets were compressed on a Huxley Bertram hydraulic com-
paction simulator equipped with 9.5 mm flat-face punches and
instrumented die. The compression profiles were created with
the compaction simulator software for a Courtoy Modul S press
(B-tooling). A 1 s profile was applied and pre-compression load
was held at 50% of the main compression load.2.10. Characterization of tablets
Hardness was measured on an ERWEKA TBH30 hardness tester
with three tablets. Disintegration time was determined on an
ERWEKA ZT71 disintegration tester in tap water at 37 C with three
tablets. Friability was measured on ERWEKA TAR20 friability tester
after 100 rounds on ten tablets.of directly compressible powder from electrospun nanofibrous amorphous
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9 April 20172.11. Raman mapping of tablets
A Horiba Jobin-Yvon LabRAM system coupled with external
785 nm diode laser source and Olympus BX-40 optical microscope
was used for collecting Raman mapping spectra. An objective of
10magnification (laser spot size: 4 µm) was applied in focusing
and spectrum acquisition. The confocal hole of 500 µm, the half of
maximum diameter, was employed in confocal system to improve
the confocal performance decreasing the analysis volume. Finally,
950 groove/mm grating monochromator disperses the Raman pho-
tons before those reach the CCD detector. The spectrograph posi-
tion was set to provide the spectral range of 460–1680 cm1 and
3 cm1 resolution. Tablets with two different API contents (one
with optimized composition and one with very low (50%) filler
fraction) were mapped by Raman instrument. The tablets were
broken in two parts and Raman mapping was performed on the
broken surface of the tablets. The maps were collected with
15 µm step size and consisted of 41  41 points. Every single spec-
trum was measured with acquisition time of 60 s and 2 spectra
were averaged at each measured point.
2.12. In vitro dissolution test
The dissolution tests were carried out on a Pharmatest PTWS
600 dissolution tester (Pharma Test Apparatebau AG, Hainburg,
Germany). Measurement parameters for neat EM: 900 mL 0.1 N
HCl, modified USPII apparatus (‘‘tapped basket” method [26]),
50 rpm paddle speed, room temperature. Measurement parame-
ters for tablets: 900 mL 0.1 N HCl, USPII apparatus, 100 rpm paddle
speed, room temperature. An on-line coupled Agilent 8453 UV–Vis
spectrophotometer (Hewlett-Packard, Palo Alto, USA) was applied
to measure the concentration of dissolved ITR at a wavelength of
254 nm. Each sample contained 50 mg of ITR.312
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3253. Results and discussion
3.1. Characterization of EM with dynamic vapour sorption (DVS)
Stability of ASDs can be directly influenced by water uptake
during downstream processing and storage. The Tg of ASD is low-
ered when water, acting as a plasticizer, is adsorbed. Below the
Tg the mobility of the matrix polymer can allow the molecules of
the API to move by diffusion and crystallize. DVS shows the water
uptake (weight gain) under certain humidity values, and thus the
stability of the EM can be predicted. According to the DVS sorption
isotherms (Fig. 1) no crystallization of ITR occurred either at 25 C
or at 40 C. If crystallization had taken place in course of DVS aFig. 1. The DVS diagram of EM
Please cite this article in press as: B. Démuth et al., Development and tableting
solid dispersion, Advanced Powder Technology (2017), http://dx.doi.org/10.10remarkable decrease in water uptake could have been noticed after
a certain humidity as crystalline materials, being less hygroscopic
than the corresponding amorphous ones, adsorb significantly less
water [38]. Presumably, at 40 C (Fig. 1b) the molecular mobility
is higher and water can penetrate into the bulk of the powder more
easily and there is no difference between the two sorption cycles.
However, at 25 C (Fig. 1a) there is a hysteresis between the two
sorption cycles with the second one looking more similar to the
sorption cycles at 40 C. Consequently, the first sorption cycle
made the EM more susceptible for water uptake.
The DVS sorption isotherms can be divided into two linear sec-
tions and the part between them. During the first period moisture
is predominantly adsorbed on the surface (first linear section, 10–
50% RH), whilst from 70% RH the moisture begins to penetrate into
the bulk of the material that starts to liquefy (second linear section,
80–95%). The transition point (intersection of the prolongation of
the two linear sections), which gives the ‘‘glass transition relative
humidity” [38], was found to be 72% at this ramping rate at both
temperatures. Below that transition phase separation is not
expected while above that it can occur.
3.2. Modulated differential scanning calorimetry (mDSC)
investigations with EM
In order to detect phase separation or slight crystallization that
might have occurred as a consequence of DVS treatment the sam-
ples were analysed by modulated DSC before and right after the
DVS measurement. The initial sample possessed single glass tran-
sition temperature (Tg) around 90 C (Fig. 2) meaning that the poly-
mer and API were well-mixed (solid solution). The recorded
temperature is in good correlation with the Fox-equation:
1
Tg
¼ w1
Tg;1
þ w2
Tg;2
where Tg is the glass transition temperature of mixture, Tg,1 and Tg,2
are the glass transition temperatures of the components (in K) and
w1 and w2 are the mass fractions of the components. The Tg of ITR
and PVPVA64 are 59.4 C [39] and 111.9 C, respectively (latter is
based on our own measurement). The sample after DVS pre-
treatment at 25 C exhibited multiple glass transitions at 62, 81
and 108 C (Fig. 2), which belong to the API-rich, mixed and the
polymer-rich phase, respectively [40]. Since no melting peak was
observed ITR did not recrystallize at 25 C, and thus it remained
amorphous. According to these results even if phases become sepa-
rated ITR is not prone to recrystallize at the 25 C. However, the DVS
pre-treatment at 40 C proved to be intensive enough to generate
recrystallization. The melting peak was not obviously apparent,at (a) 25 C and (b) 40 C.
of directly compressible powder from electrospun nanofibrous amorphous
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Fig. 2. Modulated DSC thermogram of EM before and after DVS.
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9 April 2017but two new endothermic peaks appeared on the DSC thermogram
(in the reverse heat flow) at 73 and 86 C, which can be associated
with the formation of the nematic phase of ITR [41].
Based on the results from DVS measurements (calculation of
‘‘glass transition humidity” and the difference between 25 and
40 C) the fibrous ASD was supposed to be stable at 25 C/60%
RH (with no phase separation), but not at 40 C/75% RH (with crys-
tallization). This assumption was confirmed by a short-term stabil-
ity test with mDSC (Fig. 3).
EM was placed in climate chambers for the stability test and
removed directly before the mDSC measurements. The detected
glass transition temperatures for the material after production
and storage at 25 C/60% RH after 1 day, 1 week and 1 month were
91.2 C, 90.6 C, 91.4 C and 91.4 C, respectively (Fig. 3a). The glass
transition temperature did not decrease with time and no new
glass transitions (or melting peak) have appeared on the thermo-
gram, which confirms the unchanged status of the well-mixed
components. However, at 40 C/75% RH the peaks at 73 and 86 C
appeared after one day indicating the phase transition from amor-
phous to crystalline state. After one week, the sample clearly had a
melting peak at 157 C (Fig. 3b). In our previous work it was found
that ITR in this nanofibrous ASD did not crystallize during a 1-yearFig. 3. The short-term stability test of the EM at (a) 25
Please cite this article in press as: B. Démuth et al., Development and tableting
solid dispersion, Advanced Powder Technology (2017), http://dx.doi.org/10.101stability test at 25 C/60% RH in closed holder [22]. Presumably, no
phase separation would occur during longer period.
3.3. Characterization of blends
The EM and each excipient were pushed through on a 0.95 mm
sieve prior to further application. The composition of the tableting
blends and the results of the granulometry study can be seen in
Table 1.
Bulk, tapped and true densities and the angle of reposes of the
blends are presented, furthermore Hausner ratios and Carr indexes
were derived (Table 1). The two blends exhibited similar flow
properties according to Hausner ratios, Carr index and angle of
reposes. Compared to literature data, these values suggest fair to
poor flowability for these blends although it does not seem impos-
sible to carry out the downstream process with them.
No abnormality was found in the particle size distribution of the
two blends, they possessed very similar distribution (Table 1).
According to SEM pictures of the sieve fractions, a significant
part of the material in the pan is the EM (Fig. 4a) though EM can
be found at larger particle size (75–500 µm) in aggregates
(Fig. 4b) and on the surface of fillers, rather on MCC (Fig. 4c) than
mannitol (Fig. 4d). MCC possesses a quite structured, while manni-
tol has a very flat surface; hence EM can more easily adhere to
MCC.
The sieved EM (Fig. 5a) has in fact a diverse propensity to
adhere to the surface of different fillers. Lactose served as a com-
parison since its surface is similarly structured like MCC and it is
a sugar derivative like mannitol. More fibres can be found on
MCC (Fig. 5b) and lactose (Fig. 5d) particles than on mannitol par-
ticles (Fig. 5c), which are ‘‘fibreless” on certain areas. This phe-
nomenon might have significant effect on flowability,
disintegration and dissolution.
3.4. Experimental design for the tableting of EM
In order to systematically study the effects of the compression
force and fillers fraction on the disintegration time and tensile
strength, a 32 full factorial design was planned. Friability was also
measured for those tablets of the original 22 design to obtain infor-
mation about it but evaluation for friability was not included in our
purposes.
The design of experiments and the results can be seen in Table 2.
The obtained hardness values were ranging from 70 N to 220 N.
The obtained values for every measured attribute belonged to
the usual pharmaceutical ranges.C/60% RH and (b) 40 C/75% RH (open conditions).
of directly compressible powder from electrospun nanofibrous amorphous
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Fig. 4. SEM images of sieve fractions: (a) pan, (b) 500 µm, (c) 250 µm (MCC particle) and (d) 500 µm (mannitol particles).
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For both dependent variables compression forces had the lar-
gest impact according to Pareto charts (data not shown), but other
effects – including quadratic effects - were also found to be signif-
icant. However, for tensile strength these other effects can be con-
sidered negligible due to the large difference in significance
compared to the linear effect of compression force. Therefore, a lin-
ear model between compression force and tensile strength is a rel-
atively good approximation. This observation was confirmed on
the fitted surface diagram (Fig. 6a) on which the tensile strength
was depicted in function of the fillers fraction and compression
force (according to the developed model). Tensile strength was
changing with compression force in proportion but it did not
change much with the increasing amount of fillers.
The obtained tablets had a disintegration time in the 0–14 min
range which is acceptable in the pharmaceutical technology
(immediate release tablets should disintegrate within 15 min).
Since the variance was increasing with disintegration time the
evaluation was carried out for the common logarithms of the data.
Compression force had the largest impact on disintegration time,
but - unlike in case of tensile strength - some of the other effects
also seem to be of importance e.g. the linear effect of the fillers
fraction possessed larger significance than for tensile strength. In
this case linear model would not be adequate which can be con-
firmed by the fitted surface diagram (Fig. 6b).
There was an interesting saddle point around 76% fillers fraction
and 6 kN compression force. At this point the disintegration time
should be higher than at 77.8% fillers fraction as the fillers act as
spacers among the EM particles facilitating the disintegration by
hindering the formation of gelling polymer network. However,
probably at this saddle point EM is dispersed in the tablet com-Please cite this article in press as: B. Démuth et al., Development and tableting
solid dispersion, Advanced Powder Technology (2017), http://dx.doi.org/10.10pletely while fillers cannot disrupt more EM aggregates. With more
MCC in the tablet, the bonding capacity is increased, hence the
tablet is less prone to disintegrate. This phenomenon is also
slightly visible on the tensile strength surface diagram though it
is not as extensive as in case of disintegration time.
3.5. The optimization of the tablets
With the desirability function of Statistica software it was pos-
sible to determine an optimal composition and compression force
in order to minimize the disintegration time and maximize tensile
strength (both had the same coefficient). 76.25% fillers fraction and
6 kN compression force were found to be the optimum. 6 kN com-
pression force is needed to achieve an appropriate tensile strength
which is strongly correlated with friability. After the optimization,
tablets with optimal settings were produced confirming the ade-
quacy of our model. The predicted tensile strength and disintegra-
tion time were 1.88 N/mm2 and 306 s, while experimental results
were the following: 1.94 ± 0.04 N/mm2 and 337 ± 36 s. With
regards to the deviations of the experimental results the model
can be considered precise and reliable predicting the values for
dependent variables well. Furthermore, it anticipated that tablets
with the optimal composition would have lower disintegration
time than tablets with larger amount of filler at 6 kN compression
load, which was found true. A design space, which seems to be of
great importance when exploring this unknown area, can be
defined by using design of experiments approach. Defining a
design space is a cornerstone of the important and innovative
pharmaceutical trend, Quality by Design (QbD) [42,43]. QbD has
been recently applied also to optimize a spray drying process to
obtain better ASDs from several views [44].of directly compressible powder from electrospun nanofibrous amorphous
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Fig. 5. SEM images of the (a) sieved EM, (b) EM-MCC, (c) EM-mannitol and (d) EM-lactose complexes.
Fig. 6. The fitted surface diagram of (a) tensile strength and (b) disintegration time.
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The increase of disintegration time was steeper at low fraction
of fillers than at high fraction, which indicates propensity of the
polymer to form a gelling network. In order to investigate this phe-
nomenon and distribution of EM, Raman mapping was carried out
on the cross sections of two tablets: at fraction of 76.25% fillers and
at fraction of 50% fillers (Fig. 7).Please cite this article in press as: B. Démuth et al., Development and tableting
solid dispersion, Advanced Powder Technology (2017), http://dx.doi.org/10.101In Fig. 7 mannitol appears in large uniform areas (Fig. 7c) while
mixed zones with EM and MCC can be observed as well
(Fig. 7a and b). Interestingly, EM seems to occupy more space than
it is supposed to do according to its amount in the tablet (Fig. 7a).
This can be attributed to its low density and tendency to cover
MCC with a layer resulting in apparent low value of local concen-
tration of MCC. This is in accordance with SEM images showing the
sieve fractions of tableting blend (Fig. 4).of directly compressible powder from electrospun nanofibrous amorphous
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Fig. 7. Raman maps of tablets showing the spatial distribution of (a) EM, (b) MCC, (c) mannitol. Tablet showed on the left side comprised a fillers fraction of 76.25%, while the
right one contained 50%. On the first two maps red circles indicates the sites of mannitol, black circles indicates the sites of MCC particles. (For interpretation of the references
to colour in this figure legend, the reader is referred to the web version of this article.)
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ing tablet (disintegration time 5 min) the second one (on right
side of Fig. 7) does not disintegrate completely during 2 h
(although in both cases 10% of disintegrant was incorporated in
the tablet). Obviously, at higher EM ratio the EM particles are very
close to each other whereby they can form a gelling polymer net-
work that hinders the disintegration and thus the dissolution. This
gelling polymer network is somewhat disrupted by large mannitolPlease cite this article in press as: B. Démuth et al., Development and tableting
solid dispersion, Advanced Powder Technology (2017), http://dx.doi.org/10.10particles (for instance in the middle of the map) while it can con-
tinue on the MCC particles if it has a high concentration there.
The formation of gelling polymer network can also be studied
on SEM images (Fig. 8a and b). The pictures were taken of the same
tablets as the Raman maps. On the image of the tablet with less EM
(Fig. 8a) a lot of separated areas can be discovered where fillers
increase the distance among EM particles hindering the formation
of gelling polymer network. On the other hand, the network of theof directly compressible powder from electrospun nanofibrous amorphous
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Fig. 8. SEM images of broken tablet surfaces (a) fillers fraction of 76.25%, (b) fillers fraction of 50%, (c) higher magnification to demonstrate the fibrous structure of EM in
tablets (tablet with less fillers). Red circles indicate the discontinuities of the polymer network. (For interpretation of the references to colour in this figure legend, the reader
is referred to the web version of this article.)
Fig. 9. Dissolution of ITR from pure EM, optimal tablets and crystalline ITR (n = 3).
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on the image of that tablet (Fig. 8b).
The preserved fibrous structure of EM in the tablets can be seen
at larger magnification (Fig. 8c), which is the main reason why
advantageous dissolution properties can be maintained in tablets
(Fig. 9). It can be observed that supersaturated state and complete
dissolution of ITR was achieved from tablets (just like from neat
fibres) with low deviation of the dissolved amount.521
522
523
524
525
526
5274. Conclusions
This work presents the conversion of a fibrous electrospun
material (EM) to tablet and the related characterizations, which
meets urgent scientific and industrial needs. The importance of
electrospun fibres is constantly increasing, while electrospinningPlease cite this article in press as: B. Démuth et al., Development and tableting
solid dispersion, Advanced Powder Technology (2017), http://dx.doi.org/10.101can be considered as a complementary technology to others, espe-
cially spray drying. ASDs with advantageous characteristics can be
produced by electrospinning but compared to spray drying or melt
extrusion, downstream processing and tablet formulation are not
elaborated. Dynamic vapour sorption measurement was carried
out to assess behaviour of EM under high and increasing humidity
and two different temperatures (25 and 40 C). At 25 C phases got
separated, however, only higher temperature (40 C) induced slow
recrystallization. Based on the DVS isotherms, ‘‘glass transition
humidity” was calculated (72%) and possible storage conditions
were deducted (25 C/60% RH, open conditions).
The tablet composition and compression force were optimized
by applying an experimental design with dependent variables of
disintegration time and tensile strength. It was found that EM is
prone to cover excipient particles with structured surface such as
microcrystalline cellulose or lactose (but not mannitol) and occu-
pies a significant volume in blends and tablets. These can influence
the flowability of the tableting blend, the dissolution properties
(e.g. wetting) and the formation of a gelling polymer network. This
might apply to spray dried ASDs as well due to their small particle
size and low bulk density. Fibrous structure of EM could be pre-
served during the whole downstream processing. Scanning elec-
tron microscope images confirmed the presence of fibres even in
tablets. The results demonstrate the feasibility of converting a
nanofibrous electrospun mat to industrially applicable tablets.
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